LongASNDJun 2026
Ascendis Pharma
Baird initiated a position in Ascendis Pharma as part of an increase in exposure to commercial-stage therapeutics companies with promising growth potential. The company's…
ASND
Which hedge funds are long ASND?
2 published ideas on Ascendis Pharma across 2 funds — 2 long and 0 short.
Ascendis Pharma hedge fund investment theses
Each stock pitch below comes from a fund manager's own investor letter, not a 13F filing, so it carries the reasoning behind the portfolio position on Ascendis Pharma: the full investment thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Funds with a position view
Long theses
LongASNDJun 2026
Ascendis Pharma
Baird added Ascendis Pharma as part of an increase in exposure to commercial-stage therapeutics companies with promising growth potential. Ascendis has developed a proprietary…